Ginkgo Bioworks Holdings (DNA) Stock Statistics & Valuation Metrics

Ginkgo Bioworks Holdings has a market cap or net worth of $8.38B. The enterprise value is $395.48.

Ginkgo Bioworks Holdings has 53,361,140 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ginkgo Bioworks Holdings’s return on equity (ROE) is -0.61 and return on invested capital (ROIC) is -30.05%.

The current PE Ratio of Ginkgo Bioworks Holdings is ―. Ginkgo Bioworks Holdings’s PEG ratio is 0.03.

In the last 12 months, Ginkgo Bioworks Holdings had revenue of 170.16M and earned -312.76M in profits. Earnings per share was -5.64.

In the last 12 months, operating cash flow was -165.97M and capital expenditures -17.30M, giving a free cash flow of -183.27M billion.

Ginkgo Bioworks Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Ginkgo Bioworks Holdings upcoming earnings date is Aug 6, 2026, After Close (Confirmed).

Ginkgo Bioworks Holdings as a current ratio of 4.92, with Debt / Equity ratio of 92.68%

In the past 12 months, Ginkgo Bioworks Holdings has paid -837.00K in taxes.

Ginkgo Bioworks Holdings EV to EBITDA ratio is -2.88, with an EV/FCF ratio of -4.10.

Ginkgo Bioworks Holdings has $373.46M in cash and marketable securities with $410.70M in debt, giving a net cash position of -$37.24M billion.

Gross margin is 74.97%, with operating margin of -185.29%, and net profit margin of -183.81%.

The average price target for Ginkgo Bioworks Holdings is $210.11, which is 11.43% higher than the current price. The consensus rating is Hold